VitaPath Genetics Inc.

Industry

  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
See more in Biomedtracker

Latest on VitaPath Genetics Inc.

Scrip

Start-Up Execs On The Move, October 2012

 
• By Regina Paleski

Start-Up Execs Altura Medical Inc. G. Ray Martin, PhD To:Pres. & CEO (August) From:Pres. & CEO, NovoStent Corp. Tel:949-273-5050 Celyad SA Alexander Milstein, MD To:VP, Clinincal Dev. (August)

Medtech Insight

Medical Device Deals Update, June/July 2012

Mergers & Acquisitions Alliances Elsevier’s Strategic Transactions

Scrip

Recent Financings Of Private Companies, June 2012

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Andrea Mancini, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS VitaPath Genetics Inc. VitaPath brings in $7.3mm via Series C round VitaPath Genetics Inc. (developing DNA tests to identify women at high risk for birth defects) has rais

Scrip

Start-Up Quarterly Statistics, Q2 2012

 
• By Deanna Kamienski

Financings In the second quarter of 2012, start-ups brought in a total of $556 million in financing across all industries. ( See Exhibit 1. ) Twenty biopharma companies raised $439.9 million, which wa